Use Nutraceutical International Corporation performance together with your assets to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
If you would invest 1,513 in Nutraceutical International Corporation on April 26, 2012 and sell it today you would lose (14.00) from holding Nutraceutical International Corporation or give up 0.93% of portfolio value over 30 days. Nutraceutical International Corporation is currenly generating 0.01% of daily expected returns and assumes 1.17% risk (volatility on return distribution) over the 30 days horizon. In different words, 19% of equities are less volatile than Nutraceutical International Corporation and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, Nutraceutical International Corporation is expected to generate 1.6 times more return on investment than the market. However, the company is 1.6 times more volatile than its market benchmark. It trades about 0.01 of its potential returns per unit of risk. The NYSE is currently generating roughly -0.47 per unit of risk.
Nutraceutica Operating Margin
Based on recorded statements Nutraceutical International Corporation has Operating Margin of 12.89%. This is 146.89% lower than that of Healthcare sector, and 215.5% lower than that of Drug Related Products industry, The Operating Margin for all stocks is 351.27% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Over the last 30 days Nutraceutical International Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.
1 Month Effecincy (a.k Sharpe Ratio) ...
0.01
BestPortfolio
BestEquity
Good Returns
Average Returns
Small Returns
Cash
SmallRisk
AverageRisk
HighRisk
HugeRisk
Negative Returns
NUTR
Estimated Market Risk
1.17
actual daily
81 %
of total potential
Expected Return
0.01
actual daily
1 %
of total potential
Risk-Adjusted Return
0.01
actual daily
1 %
of total potential
Based on monthly moving average Nutraceutica is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutraceutica by adding it to a well-diversified portfolio.
Follow Nutraceutica Performance with your standard RSS feed, custom widget, or your favorite social app